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Virus‐like particles (VLPs) have shown great potential as biopharmaceuticals in the market
and in clinics. Nonenveloped, in vivo assembled VLPs are typically disassembled and
reassembled in vitro to improve particle stability, homogeneity, and immunogenicity. At the
industrial scale, cross‐flow filtration (CFF) is the method of choice for performing
reassembly by diafiltration. Here, we developed an experimental CFF setup with an on‐line
measurement loop for the implementation of process analytical technology (PAT). The
measurement loop included an ultraviolet and visible (UV/Vis) spectrometer as well as a
light scattering photometer. These sensors allowed for monitoring protein concentration,
protein tertiary structure, and protein quaternary structure. The experimental setup was
tested with three Hepatitis B core Antigen (HBcAg) variants. With each variant, three
reassembly processes were performed at different transmembrane pressures (TMPs).
While light scattering provided information on the assembly progress, UV/Vis allowed for
monitoring the protein concentration and the rate of VLP assembly based on the
microenvironment of Tyrosine‐132. VLP formation was verified by off‐line dynamic light
scattering (DLS) and transmission electron microscopy (TEM). Furthermore, the experi-
mental results provided evidence of aggregate‐related assembly inhibition and showed
that off‐line size‐exclusion chromatography does not provide a complete picture of the
particle content. Finally, a Partial‐Least Squares (PLS) model was calibrated to predict VLP
concentrations in the process solution. Q2 values of 0.947–0.984 were reached for the
three HBcAg variants. In summary, the proposed experimental setup provides a powerful
platform for developing and monitoring VLP reassembly steps by CFF.
K E YWORD S
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1 | INTRODUCTION
Virus‐like particles (VLPs) are biopharmaceuticals with potential
applications against various diseases such as viral and bacterial
infections, cancer, Alzheimer’s disease, and autoimmune disorders
(Bachmann & Whitehead, 2013; Klamp et al., 2011; Kushnir,
Streatfield, & Yusibov, 2012; Lua et al., 2014; Middelberg et al.,
2011). They are generally designed to trigger an immune response by
presenting antigens on their surface. These antigens are either part
of the native viral capsid or introduced artificially. Chimeric VLPs
© 2019 The Authors Biotechnology and Bioengineering Published by Wiley Periodicals, Inc.
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were, for example, constructed based on hepatitis B core antigen
(HBcAg) (Arora, Tyagi, Swaminathan, & Khanna, 2012; Klamp et al.,
2011; Whitacre, Lee, & Milich, 2009), hepatitis B surface antigen
(HBsAg) (Kaslow & Biernaux, 2015), GH1‐Qβ (Low et al., 2014), and
murine polyomavirus VP1 (MuPyVP1) (Middelberg et al., 2011). VLPs
are resilient to most environmental stresses, have great potential to
be produced inexpensively, and efficiently elicit potent immune
responses due to their repetitive and particulate structure (Chuan,
Wibowo, Lua, & Middelberg, 2014; Kumru et al., 2014).
Similar to viruses, VLPs are assemblies of one or several types of
capsid proteins forming a higher order structure (Lua et al., 2014).
VLPs are expressed in genetically modified host organisms (Kushnir
et al., 2012; Lua et al., 2014; Vicente, Roldão, Peixoto, Carrondo, &
Alves, 2011). Subsequent production‐scale purification most fre-
quently consists of precipitation, chromatography, and ultrafiltration/
diafiltration (UF/DF) (Ladd Effio, & Hubbuch, 2015). In vivo self
assembled, nonenveloped VLPs are often disassembled and subse-
quently reassembled to remove impurities from within the capsid
(Link et al., 2012; Ren, Wong, & Lim, 2006). Disassembling and
reassembling also leads to increased structural homogeneity,
improved overall stability, and enhanced antigenicity (Mach et al.,
2006; Zhao, Allen et al., 2012, Zhao, Modis et al., 2012). An overview
of a typical VLP production process is given in Figure 1.
Generally, a change in the quaternary structure of VLPs is induced by
altering their physicochemical environment, i.e., the ionic strength of the
protein solution, the pH, or the concentration of a reducing agent (Zhao,
Allen et al., 2012). At lab scale, dialysis is the most common method for
buffer exchanges (Mach et al., 2006). Dialysis has, however, some
drawbacks such as long processing times and significant buffer
consumption (Kurnik et al., 1995). In preparative downstream processes,
cross‐flow filtration (CFF) is more popular because of its simple
scalability, reduced buffer consumption, and reduced processing time
(Jornitz, Jornitz, & Meltzer, 2008; Kurnik et al., 1995). CFF has been
successfully applied to VLPs for capture, buffer exchange, and
concentration (Russell et al., 2007; Vicente et al., 2011, 2014). Compared
with dialysis and batch diafiltration, assembly of VLPs by constant volume
diafiltration was shown to increase VLP yield (Liew, Chuan, &Middelberg,
2012). Despite the many advantages, CFF may also cause problems due
to protein‐membrane interaction (Hanemaaijer, Robbertsen, van den
Boomgaard, & Gunnink, 1989; Ko, Pellegrino, Nassimbene, & Marko,
1993), which was observed to impact process performance (Peixoto,
Sousa, Silva, Carrondo, & Alves, 2007). To reduce these problems, CFF
process time has to beminimized while maximizing the process efficiency.
Process analytical technology (PAT; Bakeev, 2010; Roch &
Mandenius, 2016; Rüdt, Briskot, & Hubbuch, 2017) is thus of interest
to monitor the assembly progress. Protein concentration measurements
allow detecting protein adsorption to the membrane. Particle size
measurements provide information on the assembly progress of the
capsid proteins into VLPs. Previous publications have also reported
effects of the VLP tertiary structure on ultraviolet and visible (UV/Vis)
and fluorescence absorption spectra (Ausar, Foubert, Hudson, Vedvick,
& Middaugh, 2006; Fang et al., 2016; Hanslip, Zaccai, Middelberg, &
Falconer, 2006; Hu et al., 2011; Rajendar et al., 2013). Following a
systematic approach to process monitoring, a combination of PAT
sensors should be chosen which allows monitoring protein concentra-
tion, protein tertiary structure, and protein size.
In this study, we developed a CFF setup consisting of a
commercial lab scale CFF device with a custom‐made on‐line
measurement loop for process analytical instrumentation. The on‐
line measurement loop included a light scattering photometer
(dynamic light scattering [DLS] and static light scattering [SLS]) and
a UV/Vis absorption spectrometer. DLS allowed for monitoring the
mean hydrodynamic diameter of particles. SLS outputs an aggregated
scattered light intensity influenced by the particle concentrations
and the diameters. Finally, UV/Vis spectroscopy provided
information on the protein concentration and on changes in the
tertiary structure by second derivative spectroscopy (Jiskoot and
Crommelin, 2005). The usefulness of the custom‐made setup was
F IGURE 1 Illustration of a typical VLP
production process. The downstream
processing train may consist of eight or
more unit operations. The unit operation
investigated here—the VLP reassembly—is
marked in blue. VLP: virus‐like particle
[Color figure can be viewed at
wileyonlinelibrary.com]
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tested for monitoring the reassembly of three different chimeric
HBcAg variants at three different transmembrane pressures (TMPs).
2 | MATERIALS AND METHODS
2.1 | Experimental setup
A custom‐made setup was developed for the CFF experiments. Figure 2
shows the setup as a piping and instrumentation diagram (P&ID). A
KrosFlo KRIIi CFF unit with a modified polyethersulfone (mPES) hollow
fiber membrane module (10 kDa cutoff, 13 cm2 membrane area) and a
50ml conical tube retentate reservoir (Spectrum Labs, Rancho Dom-
inguez, US‐CA) made up the core of the CFF unit. A Topolino Magnetic
Stirrer (IKA Werke, Staufen im Breisgau, DE) ensured homogeneous
mixing of the retentate reservoir. A T‐piece with injection plug (Fresenius
Kabi, Bad Homburg, DE) was inserted into the retentate line as sample
port to draw liquid for off‐line analytics. The retentate reservoir was
modified with two additional polyether ether ketone (PEEK) capillaries to
supply the on‐line measurement loop with liquid from the process.
In the direction of flow, the on‐line measurement loop consisted of a
Gilson Minipuls 3 peristaltic pump, a 0.7 μm particle retention Minisart
glass fiber syringe filter (Sartorius Stedim Biotech, Göttingen, DE), a
Zetasizer Nano ZSP photometer (Malvern Instruments, Malvern, UK)
with a 10‐mm pathlength flow cell (Hellma Analytics, Müllheim, DE), an
Ultimate Diode Array Detector 3000 (DAD‐3000; Dionex Corporation,
Sunnyvale, US‐CA) with a 0.4‐mm pathlength flow cell, and a FR‐902
flow restrictor (GE Healthcare, Chalfont St Giles, UK). The pump of the
on‐line measurement loop was controlled via a NI USB‐6008 data
acquisition device (National Instruments, Austin, US‐TX).
2.2 | Proteins, chemicals, and buffers
Three chimeric HBcAg constructs, i.e., VLP A, B, and C provided by
BioNTech Protein Therapeutics GmbH (Mainz, DE), were used in this
study. The HBcAg variants were recombinantly modified in the major
immunodominant region (MIR) to display three different peptides on
their surfaces (see also Figure 3). All variants were present as
homodimer stock solutions in disassembly buffer (3.5M urea, 50mM
Tris(hydroxymethyl)‐aminomethane, pH 9.0) as obtained after purifica-
tion (see also Figure 1). Protein concentration calculations were based
on extinction coefficients derived from the primary structure as
provided by the ProtParam tool (Gasteiger et al., 2005) of the Swiss
Institute of Bioinformatics (Lausanne, CH). The purity of the stock
solutions was characterized by reversed‐phase chromatography based
on the absorbance at 280 nm as described in the Supporting
Information Material B. Immediately before each experiment, stock
solutions were diluted with disassembly buffer to a protein concentra-
tion of 1 g/L (by Ultraviolet absorbance at 280 nm) and filtered through
a 0.2 μm PES 110 filter (VWR International, Radnor, US‐PA). The
reassembly buffer was a high‐salt buffer at pH 7.0.
F IGURE 2 Piping and instrumentation
diagram of the experimental setup. At the
bottom right, the on‐line measurement
loop is shown. The remaining piping is
required for the CFF. All sensors are
connected to a computer for capturing the
data centrally. Electronic communication
lines are indicated by dashed lines. I‐5 is a
pinch valve actuated by a closed loop
controller for the TMP. C: control; CFF:
cross‐flow filtration; DAD: diode array
detector; I: indicate; LS: light scattering; P:
pressure; R: record; TMP: transmembrane
pressure; U: multivariable; W: weight
F IGURE 3 An assembled HBcAg VLP is shown on the left side
(PDB ID 1QGT, (Wynne et al., 1999). The right side shows a cartoon
of a single homodimer (adapted from PDB ID 4BMG, (Alexander
et al., 2013). The tryptophan (Trp) and tyrosine (Tyr) side chains are
depicted as sticks and colored in yellow and red, respectively. Tyr
and Trp side chains located in the base of the molecule are
numbered. These residues undergo a change of hydrophobicity in
their environment during assembly. The MIR loop, whereto the
foreign epitope is inserted, is shown in blue. HBcAg: hepatitis B core
antigen; MIR: major immunodominant region; VLP: virus‐like particle
[Color figure can be viewed at wileyonlinelibrary.com]
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For size‐exclusion chromatography (SEC), 50mM of potassium
phosphate at pH 7.0 was used as running buffer. If not mentioned
otherwise, chemicals were purchased from Merck KGaA (Darmstadt,
DE). All buffers and solutions were prepared with ultrapure water
(arium pro UV; Sartorius Stedim Biotech) and filtered through a
0.2 μm pore size Supor filter (Pall, Port Washington, US‐NY)
immediately before each experiment.
2.3 | VLP reassembly monitoring
The CFF unit and the measurement loop were filled with ultrapure
water for pre‐experimental preparation. The lamps of the DAD were
turned on at least 1 hr before starting the experiments. At the end of
the equilibration phase, the absorbance signal was zeroed in
ultrapure water. Subsequently, the CFF unit and the measurement
loop were first flushed with disassembly buffer and then changed
into 25ml of protein solution. The CFF pump was set to 70ml/min
corresponding to a shear rate of approximately −6000 s 1 in the
hollow fibers. The measurement loop pump 1ml/min and data
acquisition were started.
After 5 min, constant TMP diafiltration was initiated by applying a
TMP of 0.25, 0.5, or 1 bar with reassembly buffer as diluent. 0.4 ml
samples were taken every 0.5 diafiltration volumes (DVs) via the
sample port. Experiments were stopped after 3 DV except for VLP C
for which the runs had to be terminated early due to membrane
clogging. After each run, the CFF membrane was cleaned with
ultrapure water, a 0.1M of sodium hydroxide solution, and a 15 vol%
of ethanol solution.
2.4 | Off‐line sample analysis
For SEC analysis, samples were centrifuged (Centrifuge 5810R;
Eppendorf, Hamburg, DE) at 3220 rcf for 5min to settle large particles.
The supernatant was analyzed with a Sepax SRT SEC‐1000 column
(Sepax Technologies, Newark, US‐NJ) on an Ultimate 3000 RS ultra high
performance liquid chromatography (UHPLC) system consisting of a
Pump HPG‐3400RS, an Autosampler WPS‐3000TFC, a Column
Compartment TCC‐3000RS, and a Diode Array Detector DAD‐3000
controlled by Chromeleon version 6.8 SR15 (Thermo Fisher Scientific,
Waltham, US‐MA). The run duration was 7min with a flow rate of
0.8ml/min and SEC buffer as a mobile phase. Twenty microlitre was
injected for each analysis. Samples were analyzed in triplicates.
Off‐line DLS analysis was performed using a sample volume of 45μl
in a 3x3mm quartz cuvette (Hellma Analytics, Müllheim, DE) and the
same DLS photometer as mentioned above. Unfiltered samples were
measured three times, each measurement consisting of 12–14 10 s runs
at 25°C, and 173°C backscatter. Lower and upper limits for data
processing were 1 nm and 6000nm, respectively. The measurements
were compared based on the VLP peak diameter in the regularization fit.
The photometer was also used for electrophoretic mobility
measurements of pooled and formulated samples of each construct.
The samples of different TMPs were pooled and dialyzed into a pH
7.2 buffer of 50mM Tris and 100mM sodium chloride. Samples were
filtered with a 0.2 μm PES filter (VWR International) and concentra-
tion was adjusted with Vivaspin 20 filters with a 30 kDa pore rating
(Sartorius). The sample of 50 μm was inserted into buffer‐filled folded
disposable capillary cells (DTS1070; Malvern Instruments) using a
diffusion barrier technique (Patent WO2012083272A1). Samples
were measured in pentaplicates in automatic mode. Each measure-
ment comprised a 120 s equilibration and five runs with up to 15 sub
runs. The measurements were performed at 60mV and 25°C. Zeta
potential was calculated by Zetasizer Software version 7.12 (Malvern
Instruments) assuming a material refractive index of 1.45, absorption
of 0.001, a viscosity of 0.8872 mPas, a dielectric constant of 78.54,
and a Smoluchowski approximation of 1.5 (Smoluchowski, 1921).
The VLPs were furthermore imaged by transmission electron
microscopy (TEM) on a Titan3 80–300 microscope (FEI Company,
Hillsboro, US‐OR at 80 kV in bright field mode. For sample preparation,
carbon‐coated 400‐mesh copper grids (Plano GmbH, Wetzlar, DE) were
first hydrophilized with a 1% (w/v) alcian blue 8GX (Alfa Aesar, Ward
Hill, US‐MA) for 2 min and washed five times with ultrapure water.
Subsequently, the grids were incubated for 2 min with the 0.2 μm
filtered 0.3 g/L to 0.5 g/L VLP solutions. The samples were negatively
stained with a 1% (w/v) ammonium molybdate(VI) solution (Acros
Organics, Geel, BE) at pH 7.2 for 45 s, washed, and air‐dried. VLP
diameters were measured with ImageJ 1.52a (NIH, Bethesda, US‐MD).
TEM images were processed by adjusting contrast and lightness to
improve the visibility of the VLP particles using RawTherapee version
5.5 (Gábor Horváth) image processing software.
2.5 | Data acquisition and analysis
During experiments, all integrated sensors communicated with a
custom application developed in Matlab (version R2016b; The
Mathworks, Natick, US‐MA). Next, to starting and stopping measure-
ments, the application gathered the sensor signals (three pressure
signals, the permeate weight, z‐average, and UV/Vis absorbance
spectra). Communication and control were performed through
software libraries provided by the different instrument software.
The signals were displayed on the graphical user interface (GUI) and
stored on the hard drive with a time stamp. For calculating the
permeate volume, the density of the permeate was assumed to
be ∕1 g cm3 Data acquisition and analysis of light scattering and UV/
Vis measurements were performed as described below.
2.5.1 | Light scattering measurements
The Zetasizer Nano ZSP was utilized for DLS and SLS measurements
using the chromatography flow standard operating orocedure (SOP)
of the Zetasizer software (version 7.12; Malvern Instruments). The
Zetasizer acquires data in a back‐scattering geometry at ∘173 . Each
measurement duration was 10 s. While DLS measurements were
exported on‐line, SLS data was extracted off‐line. From the DLS
measurement, the z‐average was obtained as calculated by the
Zetasizer software by the method of cumulants (Koppel, 1972).
Viscosity (0.8872 mPas), refractive indices (protein 1.45; water 1.33;
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as provided by the Zetasizer software), temperature ( ∘25 C), and flow
rate (1 ml/min) were assumed to be constant for the calculation of
the z‐average. The z‐average data was subsequently filtered by a
moving median over 60 s to remove outliers. The SLS signal was not
filtered. The transition from process Phase I to process Phase II was
detected from the scattered light intensity by the CUSUM algorithm
(Grigg, Farewell, & Spiegelhalter, 2003; Page, 1954). The transition
from process Phase II to process Phase III was set at the global
maximum of the scattered light intensity.
2.5.2 | UV/Vis absorption measurements and
processing
During VLP assembly, UV/Vis spectra were continuously acquired at 1 Hz
in the spectral range from 240 nm to 340 nm with a resolution of 1 nm.
To gain information on the local environment of aromatic amino acids,
the spectral data was filtered by a moving average over 30 s and the
second derivatives were computed with a Savitzky‐Golay filter (Savitzky
& Golay, 1964) of order 5 with a 9‐point window (Ausar et al., 2006;
Jiskoot and Crommelin, 2005). An example spectrum with the
subsequent data evaluation is shown in Figure S1 in the Supporting
Information Material A. The resulting second derivative spectra were
interpolated with a cubic spline to a final resolution of 0.01 nm. From the
interpolated data, the location of the minimum near 292.5 nm was used
as a measure of tryptophan solvent exposure (Jiskoot and Crommelin,
2005; Mach & Middaugh, 1994). The exposure of tyrosine was assessed
based on the a/b‐ratio as defined by (Ragone, Colonna, Balestrieri,
Servillo, & Irace, 1984). Briefly, the vertical distance between trough and
peak near 285 nm a was normalized by the trough‐peak distance near
294 nm b. The inflection point of the a/b‐ratio over time was computed
by taking the first derivative with a second‐order Savitzky‐Golay filter
(window width 501 points corresponding to 8.35min) and finding the
minimum.
2.5.3 | Partial‐Least Squares model calibration
Partial‐least squares (PLS) model calibration was performed in
Matlab (version 2016a). For each VLP, a PLS model was calibrated
based on the UV/Vis spectroscopic data in combination with the off‐
line SEC VLP concentration. Data of all three TMPs were included in
one model. PLS model calibration was performed similarly as
described previously (Großhans et al., 2018). The data were first
preprocessed and subsequently fitted with a PLS‐1 model by the
SIMPLS algorithm (de Jong, 1993). For preprocessing, a Savitzky‐
Golay filter with a second‐order polynomial was applied on the
spectra and, optionally, the first or second derivative was taken.
Cross‐validation was performed by iteratively excluding one sample
of each CFF run (1
7
of the data for VLP A and B, 1
6
of the data for VLP
C), calibrating a PLS model on the remaining samples (6
7
of the data
for VLP A and B, 5
6
of the data for VLP C), and calculating a residual
sum of squares on the excluded run. This procedure was repeated
until all runs had been excluded once. All residual sums of squares for
the different submodels were subsequently accumulated yielding the
predictive residual sum of squares (PRESS). The PRESS was scaled
according to Wold et al. (2001) by the number of samples and latent
variables used in the PLS model. Based on the scaled PRESS, an
optimization was performed using the built‐in genetic algorithm of
Matlab for integers (Deep, Singh, Kansal, & Mohan, 2009). The
genetic algorithm optimized the window width of the Savitzky‐Golay
filter ≤ ≤w5 21, the order of derivative ≤ ≤n0 2 as well as the
number of latent variables for the PLS‐1 model ≤ ≤N4 14. The root
mean squared error cross validation (RMSECV) was calculated from
the PRESS by dividing by the total number of samples. TheQ2 and R2
values were calculated by dividing the PRESS, respectively the
residual sum of squares, by the summed squares of the response
corrected to the mean (Wold et al., 2001).
3 | RESULTS
In this study, a new UF/DF setup with an on‐line measurement loop
was developed to monitor VLP reassembly steps. In the measure-
ment loop, a UV/Vis spectrometer and a light scattering photometer
were integrated. Furthermore, an application was implemented in
Matlab providing a GUI, communication capabilities to the different
sensors as well as a common time base for all performed
measurements. This allowed for acquiring and synchronizing mea-
surements in a controlled manner. Within the application, UV/Vis
spectra, DLS measurements, pressure, and weight readings were
immediately available for processing and display. To demonstrate the
advantages of this experimental setup, nine UF/DF runs with three
different HBcAg constructs at three different TMPs were performed.
3.1 | Monitoring of standard processes parameters
During the UF/DF processes, the initial buffer was replaced by
reassembly buffer to form HBcAg VLPs from homodimers. In Table 1,
process data of all runs are summarized (original data presented in
Figure S2 in the Supporting Information Material C). The table also
shows that the feedstock purity of VLP A was higher than VLP C and
VLP B. At 0.25 bar TMP, VLP A, B, and C showed nearly constant
increases in permeate mass over time implicating constant fluxes. The
average flux for these three runs was ∕25.8 L m2h to ∕29.1 L m2h. At 0.5
bar and 1 bar TMP, the average flux was higher for all three VLPs (from∕36.3 L m2h to ∕48.7 L m2h). CFF processes at 0.5 bar and 1 bar TMP
showed a decreasing flux over time after an initial constant phase
(except for VLP B at 0.5 bar). A decrease in flux at constant TMP
indicates the formation of a fouling layer on the membrane (Huisman,
Prádanos, & Hernández, 2000; van den Berg & Smolders, 1990).
3.2 | Process monitoring with on‐line PAT sensors
In Figures 4, 5, and 6, the on‐line PAT sensor measurements as well
as SEC off‐line analytics are shown for VLP A, B, and C, respectively.
All data were plotted over DV indicating the progress of buffer
exchange. Each figure shows the absorbance at 280 nm, off‐line VLP
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concentration measurements by SEC, second derivative spectral
analysis, and light scattering data. It is important to note that an
insufficient scattered light intensity was recorded for VLP C at 1 bar
TMP due to an incorrectly set laser attenuation. The corresponding
light scattering results were excluded. The run could not be repeated
because of material constraints.
Off‐line SEC was performed in triplicates resulting in standard
deviations smaller than 0.011 g/L. In all runs, the off‐line VLP
concentration first remained 0, followed by an increase to the
maximum VLP concentration. Thereafter, the concentration was
approximately constant or decreased slightly. Depending on the
TMP, off‐line VLP concentration started to increase at 0.5 DV to 1.5
TABLE 1 Process data is summarized for all performed runs
VLP A VLP B VLP C
TMP/bar 0.25 0.5 1 0.25 0.5 1 0.25 0.5 1
Feedstock puritya/% 73.5 22.6 44.1
Zeta potentialb/mV −7.9(7) −11.8(6) −9.5(8)
Total run time/min 118 78 75 133 75 79 108 71 70
Mean flux/( − −Lm h2 1) 30.5 46.9 48.4 26.8 48.7 45.9 27.6 36.3 40.0
Max. VLP conc./(g/L) 0.248 0.275 0.250 0.126 0.133 0.116 0.134 0.103 0.126
Inflection a/b‐ratio/DV 1.5 0.8 0.7 1.5 1.4 0.7 1.6 0.9 0.6
VLP peak diameterc/nm 40(6) 46(11) 42(7) 35(5) 40(11) 46(10) 41(12) 48(5) 36(11)
Note. TMP: transmembrane pressure; VLP: Virus‐like particle.
aAssessed by reversed‐phase chromatography as described in the Supporting Information Material B.
bMedian and median absolute deviation in parenthesis.
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F IGURE 4 The figure displays the on‐line sensor measurements as well as off‐line analytics against the DV of VLP A. The rows display
measurements of different sensors. Top row: Off‐line VLP♢ and aggregate○ concentration measurements by SEC, UV absorbance at 280 nm –.
Middle row: DLS and SLS measurements. Roman numbers indicate the different process phases. Bottom row: Second derivative spectral
analysis for tyrosine (a/b‐ratio) and tryptophan (location of the minimum around 292.5 nm). The inflection point of the a/b‐ratio is marked by a
vertical bar. The columns correspond to different TMPs. Left column: 0.25 bar, middle column: 0.5 bar, right column: 1 bar. At 0.25 bar TMP the
z‐average is corrupted with noise early in the process. DLS: dynamic light scattering; DV: diafiltration volume; SEC: size‐exclusion
chromatography; SLS: static light scattering; TMP: transmembrane pressure; VLP: virus‐like particle [Color figure can be viewed at
wileyonlinelibrary.com]
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DV. The higher the TMP, the lower the DV at which the assembly
onset occurred. The maximum observed VLP concentration was
between 0.248 g/L and 0.275 g/L for VLP A, between 0.116 g/L and
0.133 g/L for VLP B, and between 0.103 g/L and 0.134 g/L for VLP C.
The SEC aggregate content was between 5% and 15% of the VLP
concentration.
UV absorbance at 280 nm decreased in all runs over time. Small
step‐like decreases were due to sampling for off‐line analytics. The
drawn sample volume was replaced by reassembly buffer resulting in
dilution of the process liquid. For VLP A, B, and C, a rapid decrease in
the absorbance at 0.25 bar TMP occurred towards the end of the
runs, suggesting a loss of protein.
Solvatization of aromatic amino acids and particle formation
were observed during CFF by on‐line UV/Vis and light scattering
measurements. UV/Vis spectral data were examined by second
derivative analysis. From the derived spectra, characteristics
were calculated for the solvatization of tryptophan (location of
the minimum around 292.5 nm) and tyrosine (a/b‐ratio; Jiskoot
and Crommelin, 2005). For all runs, a shift towards longer
wavelengths of the tryptophan minimum was observed, while the
a/b‐ratio decreased. Both trends indicated an increase in the
mean hydrophobicity around tryptophans and tyrosines. Espe-
cially for higher TMPs, the characteristics followed a sigmoidal
curve shape. The inflection points of the a/b‐ratio in all runs were
marked by a vertical line and were located either around 0.8 DV
or 1.5 DV (see Table 1).
DLS measurements were interpreted based on the z‐average. In
all experiments, an initial phase of relatively constant z‐average
values below 20 nm was observed. The second phase was
characterized by a rapid increase in z‐average to around 40 nm for
TMPs of 0.5 bar and 1 bar. At a TMP of 0.25 bar, the second phase
showed a larger increase of the z‐average to 50 nm to 80 nm. The
third phase resulted in relatively constant z‐averages over time.
SLS measurements are influenced by the particle diameter and
concentration. Similar to the z‐average, scattered light intensities
started to increase after an initial constant phase. The increase
continued even after the z‐average reached a plateau and eventually
flattened. For VLP A and C at 0.25 bar TMP, scattered light
intensities rapidly decreased towards the end of the runs.
At 0.5 bar and 1 bar, z‐averages, scattering intensities, and SEC
VLP concentrations of each run started to increase simultaneously
within off‐line time resolution. Interestingly, for processes at
0.25 bar, the z‐averages and scattering intensities increased earlier
than VLP and aggregate concentration by SEC. The initial increase in
Phase II at 0.25 bar ended at high z‐averages> 45 nm, not observed in
the other processes. In all runs, the inflection point of the a/b‐ratio
occurred around the steepest increase in the VLP concentration
by SEC.
F IGURE 5 The figure displays the on‐line sensor measurements as well as off‐line analytics against the DV of VLP B. The rows display
measurements of different sensors. Top row: Off‐line VLP ♢ and aggregate○ concentration measurements by SEC, UV absorbance at 280 nm –
Middle row: DLS and SLS measurements. Roman numbers indicate process phases. Bottom row: Second derivative spectral analysis for tyrosine
(a/b‐ratio) and tryptophan (location of the minimum around 292.5 nm). The inflection point of the a/b‐ratio is marked by a vertical bar. The
columns correspond to different TMPs. Left column: 0.25 bar, middle column: 0.5 bar, right column: 1 bar. DLS: dynamic light scattering; DV:
diafiltration volume; SEC: size‐exclusion chromatography; SLS: static light scattering; TMP: transmembrane pressure; VLP: virus‐like particle
[Color figure can be viewed at wileyonlinelibrary.com]
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3.3 | Selective prediction of VLP concentration by
PLS modeling
The PLS model calibration results are shown in Figure 7 and Table 2.
Figure 8 shows the PLS regression coefficients. All PLS models were
fitted to the second derivative of the UV/Vis spectral data with 6–9
latent variables. The achievedQ2 values were 0.984, 0.984, and 0.947
for VLP A, B, and C, respectively.
3.4 | Analysis of post‐assembly samples
Off‐line DLS data were measured at the end of all processes. The VLP
peak diameter data is shown in Table 1. The mean diameter across all
runs was 41 nm with a standard deviation of 11 nm. VLP B had the
most negative zeta potential with −11.8(6) mV, followed by VLP C
with −9,5(8) mV, and VLP A with −7,9(7) mV.
F IGURE 6 The figure displays the on‐line sensor measurements as well as off‐line analytics against the DV of VLP C. The rows display
measurements of different sensors. Top row: Off‐line VLP ♢ and aggregate ○ concentration measurements by SEC, UV absorbance at 280 nm –.
Middle row: DLS and SLS measurements. Roman numbers indicate process phases. Bottom row: Second derivative spectral analysis for tyrosine (a/b‐
ratio) and tryptophan (location of the minimum around 292.5 nm). The inflection point of the a/b‐ratio is marked by a vertical bar. The columns
correspond to different TMPs. Left column: 0.25 bar, middle column: 0.5 bar, right column: 1 bar. DLS and SLS measurements at 1 bar were excluded
because of an erratically set laser attenuator. DLS: dynamic light scattering; DV: diafiltration volume; SEC: size‐exclusion chromatography; SLS: static
light scattering; TMP: transmembrane pressure; VLP: virus‐like particle [Color figure can be viewed at wileyonlinelibrary.com]
F IGURE 7 A PLS model was fitted to the UV/Vis spectral data for each construct to predict the concentration of assembled VLPs. The
concentration estimated by the calibrated PLS model is compared with off‐line analytics in the current plot. Each TMP is reflected by a color.
The markers show the concentration measured by off‐line analytics while the lines correspond to the concentrations estimated by the PLS
model. PLS: partial‐least squares; TMP: transmembrane pressure; VLP: virus‐like particle [Color figure can be viewed at wileyonlinelibrary.com]
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TEM images (Figure 9) showed hollow spherical particles with a
mean diameter of 33(3) nm, 32(2) nm, and 31(2) nm for the
formulated and filtered solution of VLPs A, B, and C, respectively.
This result is well in agreement with the DLS measurements and
literature data (Crowther et al., 1994).
4 | DISCUSSION
4.1 | On‐line measurement setup
As shown in Figure 2, the experimental setup included a flow
restrictor and a filter next to the sensors in the on‐line measurement
loop. The flow restrictor and filter were added to improve the
measurement quality. The flow restrictor set a minimal back pressure
in the measurement loop reducing pressure fluctuations and air
bubbles. The filter (cutoff, 0.7 μm) retained bubbles and large
particles adversely affecting light scattering measurements. The light
scattering measurements depend strongly on the particle diameter
d(Bohren & Huffman, 2004). Thus, large particles, such as air bubbles
or large aggregates, can completely overshadow the light scattering
of smaller particles in SLS and DLS measurements.
4.2 | Interpretation of SLS and DLS measurements
During VLP reassembly, anticipated particles in the process solution
were homodimers, VLPs, VLP aggregates, and process‐related
impurities, all of which contributed to light scattering. Thus, the
scattered light intensity is a sum signal generated by all scattering
species. By neglecting any interaction between the particles and
assuming Rayleigh scattering, the scattered light intensity IR can be
described as (Bohren & Huffman, 2004)




where i iterates overall species, ci is the molar concentration of
species i, and di is the diameter of species i. Based on this formula, it
can be verified that particle agglomeration and concentration leads
to increased scattered light intensities.
The z‐average is the intensity‐weighted harmonic mean hydro-
dynamic diameter (Thomas, 1987). Therefore, the z‐average is not
proportional to the concentration but reflects an apparent mean
particle diameter. A small fraction of large particles can still
significantly increase the z‐average. During reassembly, an increase
of scattered light intensity and z‐average was expected because of
the formation of VLPs and aggregates.
4.3 | DLS measurements inflow
DLS measures the time correlation of scattered light intensity. In
contrast to the typical DLS measurement setup, the time correlation
in the on‐line measurement loop was not only influenced by diffusion
but also by convective flow (Berne & Pecora, 2000). It has been
previously demonstrated that the convective flow results in
increased estimated diffusion coefficients and thus in reduced
particle diameters (Leung, Suh, & Ansari, 2006). The effect was
shown to be more pronounced for larger particles. Consequently,
underestimation of particle sizes was expected to be more
pronounced for aggregates than VLPs than homodimers. No effect
on SLS was expected from convective flow.
4.4 | General considerations on the VLP assembly
processes
During the diafiltration process, the disassembly buffer was gradually
exchanged by an assembly buffer. The chemical environment of the
HBcAg dimers increasingly favored assembly. This is different to the
TABLE 2 Spectral preprocessing parameters, parameters for the
PLS model, and the prediction quality of the chemometric models are
summarized
VLP A VLP B VLP C
No. of samples 21 21 18
No. of cross‐validation groups 7 7 6
No. of latent variables 6 9 7
Window Savitzky‐Golay filter 7 9 9
Derivative 2 2 2
R2 0.995 0.997 0.994
Q2 0.984 0.984 0.947
RMSECV/(g/L) 0.01 0.01 0.01
Note. PLS: partial‐least squares; RMSECV: root mean squared error cross
validation; VLP: virus‐like particle.
F IGURE 8 Regression coefficients of the three PLS models. Each
row corresponds to the regression coefficients of one VLP in black
while the other regression coefficients are supplemented in gray.
PLS: partial‐least squares; VLP: virus‐like particle
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conventional approach in VLP kinetic studies where the composition
of the assembly reaction liquid is usually adjusted by rapid dilution
(Mukherjee, Thorsteinsson, Johnston, DePhillips, & Zlotnick, 2008;
Zlotnick, Johnson, Wingfield, Stahl, & Endres, 1999). In said studies,
assembly equilibrium phases were reached in a few minutes. Given
the comparably large time frame of diafiltration experiments
(75min–135min), we assume that the VLP concentration was almost
exclusively dependent on the buffer composition.
Figure 10 illustrates the formation of particles out of HBcAg
dimers during a diafiltration process and expected sensor responses.
The diafiltration process was split into Phases I to III based on
different reactions occurring during each phase.
F IGURE 9 TEM micrographs of the formulated VLP A, B, and C after the end of the assembly process by CFF. CFF: cross‐flow filtration;
TEM: transmission electron microscopy; VLP: virus‐like particle
F IGURE 10 Theoretical consideration of particle formation during the assembly process by CFF. Homodimers, aggregates, and VLPs are
shown as schematics. The expected development of SLS, z‐average, and VLP concentration signals is shown over the CFF process progress
subdivided into four phases. In the process, the buffer of a homodimer solution is gradually exchanged by assembly buffer to initiate VLP
assembly. In Phase I, few aggregates are formed and no assembly takes place. The formation of aggregates increases the light scattering signals
while the VLP concentration remains 0. As a consequence of exceeding a critical buffer composition, VLPs start to form in Phase IIa, visualized
by an increase in VLP concentration. The light scattering signals continue to increase as a response to particle formation. In Phase IIb, assembly
continues, indicated by a further increase in VLP concentration and static light scattering. The z‐average remains comparably constant as its
value is already close to the actual VLP diameter and is thus only marginally influenced by further assembly. In Phase III, the assembly reaction
is no longer proceeding. Particles are depleted resulting in a decrease in the light scattering signals. CFF: cross‐flow filtration; SLS: static light
scattering; VLP: virus‐like particle [Color figure can be viewed at wileyonlinelibrary.com]
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In Phase I, buffer exchange starts but no assembly occurs, i.e., the
VLP concentration remains 0. However, aggregates may form
resulting in an increase in scattered light intensity and z‐average,
as seen in Figures 4, 5, and 6.
In Phase II, homodimers assemble into VLPs. Native HBcAg VLPs
are 30 nm to 34 nm in diameter (Crowther et al., 1994). VLP
concentration increases to its maximum, while the scattered light
intensity and z‐average continue to rise. To explain the sensor
response more comprehensively, Phase II was subdivided into two
subphases, IIa and IIb. In subphase IIa, z‐average and scattered light
intensity both increase. In subphase IIb, scattered light intensity
further increases while z‐average remains constant. The increase in
scattered light intensity is caused by the ongoing formation of VLPs
and aggregates. Conversely, the z‐average stagnates as it is an
intensity‐weighted harmonic mean. Native HBcAg VLPs are 30 nm to
34 nm in diameter (Crowther et al., 1994). When the z‐average is
close to the size of VLPs, further assembly has only a small effect on
the z‐average, while the scattered light intensity still increases due to
the formation of particles.
In Phase III, the VLP concentration no longer increases. Thus, the
end of the assembly process is reached. A loss of aggregates is
reflected by a decrease in z‐average and scattered light intensity. A
decrease in scattered light intensity and UV absorbance with
constant z‐average reflects a decrease in overall protein concentra-
tion with constant particle size distribution.
Towards the end of some processes (most pronounced for VLP A
and C at 0.25 bar), both light scattering signals decreased combined
with a decrease in the UV signal at 280 nm. Thus, the protein
concentration decreased due to adsorption to the CFF membrane or
retention on the measurement loop filter. The elevated salt
concentration of the process liquid at this stage of the process may
have promoted adsorption of protein to the hollow fiber membrane
(Hanemaaijer et al., 1989). In both runs, the z‐average started to
decrease already earlier than the UV signal at 280 nm around the
location of the inflection point of the a/b‐ratio while the UV
absorbance was still approximately constant. This could indicate a
partial disintegration of aggregates. Phase III was generally short, as
either its onset was close to the final DV or the process was stopped
early due to membrane fouling.
The assembly of HBcAc VLPs also induces changes in mean
hydrophobicity around aromatic amino acids as capsid assembly
relies on hydrophobic interaction forces (Venkatakrishnan & Zlot-
nick, 2016; Wynne et al., 1999). Tyrosine‐132 is especially important
for the assembly (Bourne, Katen, Fulz, Packianathan, & Zlotnick,
2009). In homodimers, tyrosine‐132 is highly solvent‐exposed, as
shown in Figure 3. After VLP assembly, tyrosine‐132 is buried in a
hydrophobic pocket of the neighboring homodimer. During diafiltra-
tion, the solvatization of tyrosine changes because of aggregation as
well as VLP assembly. If the mean effect on hydrophobicity by
aggregation is small compared to the mean effect caused by
assembly, the change over time of the a/b‐ratio correlates to the
rate of assembly. As a result, the a/b‐ratio’s inflection point marks
the point of the highest rate of assembly. Similarly, the increase in the
wavelength of the tryptophan absorption minimum marks an
increase in hydrophobicity around tryptophans. Since the change in
the solvent exposure of tryptophans during VLP assembly is less
pronounced, the effect is weaker and more biased by aggregation.
4.5 | CFF for VLP assembly
VLP A was assembled from the purest dimer stock solution of the
three investigated VLPs. The process was thus expected to perform
comparably well. This agreed with the experimental results at 0.5 bar
and 1 bar TMP. The observed z‐averages of 28 nm to 29 nm in Phase
III showed that there was a significant fraction of VLPs. Few large
particles were generated while other factors such as the flow
reduced the z‐average compared with off‐line DLS analytics (see
Table 1). The higher final z‐average and an elevated scattered light
intensity at 0.25 bar TMP provided evidence of the formation of large
aggregates. The observations made for VLP A were in general also
applicable to VLP B and C. Both VLPs were adversely affected at
lower TMPs by aggregation reflected by increased z‐averages and
light scattering intensities.
A further interesting result of this study was the clustering of the
inflection points of the a/b‐ratio either around 1.5 DV or around 0.8
DV. An early inflection point is consistent with early VLP formation.
Conversely, a late inflection point correlated to an early increase in
aggregates. By keeping in mind that the DV is indicative of the
progress of buffer exchange, the conclusion may be drawn that VLP
assembly is inhibited by aggregates. Indeed, a similar conclusion was
previously proposed for MuPyVP1 VLPs (Ding, Chuan, He, &
Middelberg, 2010). Ding and coworkers described a competition of
capsomere association into aggregates and precursors of Mu-
PyVP1 VLPs.
The results of the diafiltration experiments for all VLPs showed
that a low TMP of 0.25 bar lead to an increased aggregation
propensity and an increased process time compared with the other
conditions. At 0.5 bar and 1 bar TMP, the process time, VLP
concentration, and aggregate content depended on the VLP
construct and stock purity but were not solely dependent on the
TMP. For increased yield and decreased aggregate content, it could
be helpful to introduce a further purification step for VLP B and C. In
all runs, aggregate concentration by SEC did not reflect the data
obtained by light scattering. The reason for this seemed to be that
large aggregates were depleted during sample preparation or in the
SEC column. As a consequence, light scattering provided a more
complete picture of the aggregate content.
Process Phase III is characterized by product loss. The process
should therefore be terminated at the end of Phase II. It is worth
noting that the end of Phase II is influenced by the VLP construct but
seems to be independent of the applied TMP. No plateau or decrease
in assembly was observed for VLP B. VLP B was charged strongest,
requiring higher ionic strengths to overcome the electrostatic
charges of the homodimers during assembly (see Table 1). Zeta
potentials of VLP A and C are similar. For both, a transition into
Phase III was observed.
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To compare the assembled VLPs with standard characterization
methods, we performed DLS and TEM measurements on the
assembled VLPs. Off‐line DLS VLP peak diameters with a mean of
41 nm and a standard deviation of 11 nm are comparable with that of
wild type HBcAg VLPs (typically 30 nm to 34 nm (Crowther et al.,
1994). No significant influence of the TMP or construct on the final
VLP peak diameter could be observed. TEM measurements con-
firmed the existence of assembled VLPs for all three constructs in the
expected size range.
In summary, the analytical measurements of the VLP size and
structure confirm the information obtained from the PAT tools.
4.6 | Benefits of using PAT for process
development and production
PAT is currently a frequently investigated approach to increasing the
acquired information about unit operations in biopharmaceutical
process development and production by timely measurements.
Generating information on the process in (near) real‐time potentially
results in a better understanding, faster optimization, and reduced
off‐line analytical samples (Bakeev, 2010).
Here, the UV absorbance at 280 nm provided insight into changes
in the concentration of protein and other absorbing species in real
time. This can be of advantage for assessing the membrane
performance (e.g., membrane fouling, pore rating out‐of‐specification,
or membrane damage). A mechanistic understanding is, however,
often not possible solely based on a single wavelength. A more in‐
depth view on the ongoing processes during UF/DF could be realized
based on the acquired UV/Vis spectra. For HBcAg, tyrosine‐132 is
especially important for the VLP assembly. The a/b‐ratio provides a
mechanistic insight into the assembly reaction based on the mean
tyrosine solvatization. Next to means for quantification, the UV/Vis
spectrometer implemented in the presented setup thus provides
mechanistic process understanding. Furthermore, other UV/Vis
chromophores are phenylalanine, tryptophan, and disulfide bridges
(Jiskoot and Crommelin, 2005). These may be affected during the
assembly of other VLPs. For example, during the assembly of human
papilloma virus‐like particles, disulfide bridges are the key to the
formation of higher order structures (Li, Beard, Estes, Lyon, &
Garcea, 1998). An assembly process with these VLPs could therefore
be monitored with a UV/Vis spectrometer.
Another changing protein attribute which can be monitored is the
particle size. The significant increase in size has a large impact on the
scattering characteristics of the process fluid. The light scattering
photometer thus allowed for the detection of the start of the
assembly reaction and maximum VLP concentration. Light scattering
photometers are universal detectors that are not dependent on the
protein primary structure. As a consequence, any VLP assembly
reaction can be monitored with this technique. In development and
production, light scattering detectors provide the means for
detecting the ideal point to stop CFF or to initiate the next process
step. This can improve the product quality (as process Phase III is
omitted) and allow for process intensification.
Generally, the on‐line sensors provide data with high temporal
resolution which typically is difficult to achieve with off‐line analytics.
In consequence, smaller changes in process characteristics (e.g.,
assembly onset, end of Phase II) can be detected. This may be helpful
for the further assessment of different processes in development or
for detecting deviations or hidden trends in production.
For process monitoring in production, it may be beneficial to
retrieve VLP concentrations in real time. A PLS model was thus
developed to demonstrate the possibility to monitor VLP concentra-
tion on‐line by UV/Vis spectroscopy. The model was optimized by a
constrained heuristic search algorithm. The minimal number of four
latent variables was set to reflect the minimal amount of independent
UV‐active species (VLP concentration, deoxyribonucleic acid (DNA)
concentration, urea concentration, and aggregates). Reliable VLP
concentration estimations were possible for all three constructs. In
production, UV/Vis measurements in conjunction with a PLS model
could thus be used for the real‐time assessment of the assembly
progress and ultimately for process control. Based on the regression
coefficients of the PLS model (Figure 8), it is clearly visible that the
fine structure of the tyrosine and tryptophan absorption is of major
importance for the regression. Therefore, the PLS model accesses
information similar to that provided by the a/b‐ratio and the
tryptophan minimum. The differences between the regression
coefficients for VLP A, B, and C were attributed to the changing
purity of the stock solutions. Provided that no additional chromo-
phores are introduced into the MIR, a universally applicable PLS
model for different HBcAg constructs is conceivable. This may be
evaluated further in future studies.
5 | CONCLUSION AND OUTLOOK
In this study, we investigated HBcAg assembly by diafiltration of
three different constructs at three different TMPs. We developed an
on‐line measurement setup consisting of a UV/Vis and a light
scattering sensor (DLS and SLS) with a unified software platform.
This setup allowed for monitoring mean particle sizes, hydrophobicity
around tyrosine and tryptophan as well as the protein concentration.
VLP particle formation was verified by off‐line DLS measurements
and TEM imaging. Based on the acquired UV/Vis spectra, we
calibrated three PLS models for estimating VLP concentrations in
real‐time. Regarding process performance, we observed that pro-
cesses with hollow fiber modules at 0.25 bar TMP resulted in
increased aggregation. In all processes, the maximum rate of
assembly occurred around two characteristic DV. This behavior
was interpreted as a result of aggregation‐related inhibition of VLP
assembly, which makes it especially important to prevent aggregation
in a VLP assembly process. The maximum VLP concentration
coincided with the maximum light scattering intensity. Thus, the
light scattering peak or the calibrated PLS model could potentially be
used as PAT decision tools for VLP assembly process control leading
to improved product quality and intensified processes. In summary,
the established setup has shown great potential for improving
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process monitoring, development, and understanding during VLP
assembly by diafiltration.
In the future, strategies may have to be developed for process
control during VLP reassembly. The proposed setup allowed for
monitoring central quality attributes during the process with and
without calibrated chemometric models. It is therefore a good
starting point for any further research in this direction. From a
process development point of view, the current results have not yet
shown a reduced process efficiency at the highest TMP. A further
increase in TMP may thus be attractive. Alternative membrane
options, such as membrane cassettes, could strongly affect the
process and may be interesting to evaluate with the setup.
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